PKM and cancer: Similarly, PKM2 expression was shown to be negatively correlated with the prognosis of 8 out of 12 cancers (cox p < 0.05), including blood, brain, breast, colorectal, eye, lung, prostate, and soft-tissue cancers (Fig. 2C).